BARNETTE K GARY
Known title: Chief Scientific OfficerCIK: 0001314913
BARNETTE K GARY's purchase track record
BARNETTE K GARY has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/13/2026 | VERU | $5K | pending | pending | — |
| 5/24/2024 | VERU | $7K | -30.1% | -44.7% | +12.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| VERU | ▲ Buy | Open Market | 1,800 | $5K | 8/13/2026 | View on chart |
| VERU | ▲ Buy | Open Market | 5,000 | $7K | 5/24/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
WestPark Capital initiates Veru coverage with $28 target
WestPark Capital has started tracking Veru Inc. with a positive outlook and set a price target of $28. This new analyst coverage places the firm's estimate above the current average analyst target of $24.50. The stock is currently trading near its 52-week low, making this fresh initiation a notable data point for investors watching the ticker.
WestPark Capital initiates Veru coverage with $28 target. WestPark Capital has started tracking Veru Inc. with a positive outlook and set a price target of $28. This new analyst coverage places the firm's estimate above the current average analyst target of $24.50. The stock is currently trading near its 52-week low, making this fresh initiation a notable data point for investors watching the ticker.